Cocaine is a highly addictive drug that binds to the dopamine transporter (
DAT), inhibits the reuptake of dopamine, and initiates multiple actions wit
hin midbrain dopaminergic systems. Using the rhesus monkey, we have investi
gated the consequences of in utero cocaine exposure on the expression of DA
T in the fetal brain. By using the selective DAT ligand [I-125]RTI-121 and
tyrosine hydroxylase (TH) immunocytochemistry, we found that DAT binding si
tes are highly developed by day 70 of gestation and show a distribution pat
tern similar to TH. The rank order of specific 3 beta-(4-[I-125]iodophenyl)
tropane-2 beta-carboxylic acid isopropyl ester ([I-125]RTI-121) binding den
sities was substantia nigra-ventral tegmental area > putamen > caudate > la
teral hypothalamus > accumbens > linear/interfascicular nuclei greater than
or equal to globus pallidus > prefrontal cortex. Furthermore, we observed
that DAT mRNA was differentially expressed within fetal midbrain dopamine n
eurons with the highest levels detected in the ventral tier of the substant
ia nigra pars compacta, and the lowest levels in the ventral tegmental area
and the linear/interfascicular nuclei. In utero cocaine exposure between d
ays 22 and 70 significantly increased DAT mRNA expression, and the density
of [I-125]RTI-121 binding sites within midbrain dopamine neurons in the 70-
d-old fetus. This increased DAT expression is accompanied by other presynap
tic and postsynaptic neuronal changes, which collectively suggest that midb
rain dopamine neurons are hypoactive after prolonged cocaine exposure, a st
ate that may be a contributing factor in the development of attention defic
it disorders observed in subjects exposed prenatally to cocaine.